Kei Tomihara

1.2k total citations
81 papers, 889 citations indexed

About

Kei Tomihara is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Kei Tomihara has authored 81 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 18 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Kei Tomihara's work include Head and Neck Cancer Studies (12 papers), Oral and Maxillofacial Pathology (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Kei Tomihara is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Oral and Maxillofacial Pathology (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Kei Tomihara collaborates with scholars based in Japan, United States and Indonesia. Kei Tomihara's co-authors include Makoto Noguchi, Kumiko Fujiwara, Tyler J. Curiel, Bin Zhang, Kenji Nakamori, Naoya Arai, Hirofumi Hamada, Qing‐Li Zhao, Hiroyoshi Hiratsuka and Toshihiro Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Kei Tomihara

71 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kei Tomihara Japan 17 269 230 222 142 109 81 889
Qingxuan Wang China 21 143 0.5× 589 2.6× 152 0.7× 115 0.8× 98 0.9× 56 1.4k
So‐Young Choi South Korea 18 219 0.8× 361 1.6× 64 0.3× 153 1.1× 143 1.3× 83 1.0k
Canhua Jiang China 19 200 0.7× 462 2.0× 142 0.6× 81 0.6× 221 2.0× 100 1.2k
Ieyoshi Kobayashi Japan 21 282 1.0× 457 2.0× 142 0.6× 260 1.8× 176 1.6× 53 1.1k
Dominik Horn Germany 17 398 1.5× 504 2.2× 165 0.7× 45 0.3× 240 2.2× 62 1.1k
Kalu U.E. Ogbureke United States 18 247 0.9× 589 2.6× 85 0.4× 274 1.9× 73 0.7× 43 1.4k
Flávia Caló de Aquino Xavier Brazil 15 116 0.4× 291 1.3× 48 0.2× 167 1.2× 122 1.1× 73 726
E. Cassagnau France 18 224 0.8× 199 0.9× 79 0.4× 50 0.4× 228 2.1× 50 822
Chengzhe Yang China 21 207 0.8× 511 2.2× 234 1.1× 37 0.3× 108 1.0× 43 1.1k
Yoichi Ohiro Japan 12 151 0.6× 262 1.1× 77 0.3× 42 0.3× 72 0.7× 51 576

Countries citing papers authored by Kei Tomihara

Since Specialization
Citations

This map shows the geographic impact of Kei Tomihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Tomihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Tomihara more than expected).

Fields of papers citing papers by Kei Tomihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Tomihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Tomihara. The network helps show where Kei Tomihara may publish in the future.

Co-authorship network of co-authors of Kei Tomihara

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Tomihara. A scholar is included among the top collaborators of Kei Tomihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Tomihara. Kei Tomihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hirai, Hideaki, N. Kinoshita, Yu Oikawa, et al.. (2024). Treatment strategies for patients over 80 years of age with oral squamous cell carcinoma. Surgical Oncology. 57. 102146–102146. 1 indexed citations
3.
Kurokawa, Akira, et al.. (2024). Association between salivary inflammatory mediators and oral mucositis in patients with cancer undergoing chemotherapy. Supportive Care in Cancer. 32(9). 625–625.
4.
Tomihara, Kei, et al.. (2023). Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy. SHILAP Revista de lepidopterología. 11(12). e8219–e8219. 3 indexed citations
5.
Maruyama, Satoshi, Manabu Yamazaki, Tatsuya Abé, et al.. (2023). Liquid‐based cytology for differentiating two cases of pemphigus vulgaris from oral squamous cell carcinoma. Diagnostic Cytopathology. 51(5). E170–E175. 1 indexed citations
6.
Sakamaki, Ippei, Wakana Ohashi, Yukië Tanaka, et al.. (2021). Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells. Scientific Reports. 11(1). 24154–24154. 1 indexed citations
7.
Tomihara, Kei, et al.. (2019). Alterations in composition of immune cells and impairment of anti-tumor immune response in aged oral cancer-bearing mice. Oral Oncology. 99. 104462–104462. 18 indexed citations
8.
Hamashima, Takeru, Yoko Ishii, Seiji Yamamoto, et al.. (2018). Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast. Cellular Physiology and Biochemistry. 51(3). 1461–1479. 10 indexed citations
9.
Noguchi, Makoto, et al.. (2017). Primary peri-implant oral intra-epithelial neoplasia/carcinoma in situ: a case report considering risk factors for carcinogenesis. SHILAP Revista de lepidopterología. 3(1). 47–47. 9 indexed citations
11.
Inoue, Sayaka, Naoya Arai, Kei Tomihara, et al.. (2015). Extracellular Ca2+-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells. European Journal of Pharmacology. 761. 44–54. 5 indexed citations
12.
Yoshida, Toshiko, Motonori Okabe, Chika Koike, et al.. (2013). CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Oral Oncology. 49(8). 787–795. 57 indexed citations
13.
Shin, Tahiro, Sara Ludwig, Bin Zhang, Tyler J. Curiel, & Kei Tomihara. (2012). Aging-associated B7-DC+ B cells enhance anti-tumor immunity (162.24). The Journal of Immunology. 188(1_Supplement). 162.24–162.24. 2 indexed citations
14.
Tomihara, Kei, Vincent Hurez, Hideo Yagita∥, et al.. (2011). Aging‐associated B7‐DC+ B cells enhance anti‐tumor immunity via Th1 and Th17 induction. Aging Cell. 11(1). 128–138. 22 indexed citations
15.
Tomihara, Kei, Miao Guo, Xiuhua Sun, et al.. (2010). Antigen-Specific Immunity and Cross-Priming by Epithelial Ovarian Carcinoma-Induced CD11b+Gr-1+ Cells. The Journal of Immunology. 184(11). 6151–6160. 40 indexed citations
16.
Ishiwata, Kenji, Naohiro Watanabe, Miao Guo, et al.. (2010). Costimulator B7-DC Attenuates Strong Th2 Responses Induced by Nippostrongylus brasiliensis. The Journal of Immunology. 184(4). 2086–2094. 32 indexed citations
17.
Nakamori, Kenji, Kumiko Fujiwara, Akihiro Miyazaki, et al.. (2008). Clinical Assessment of the Relationship Between the Third Molar and the Inferior Alveolar Canal Using Panoramic Images and Computed Tomography. Journal of Oral and Maxillofacial Surgery. 66(11). 2308–2313. 78 indexed citations
18.
Masuta, Yukari, Kazunori Kato, Kei Tomihara, et al.. (2007). Gene Transfer of Noncleavable Cell Surface Mutants of Human CD154 Induces the Immune Response and Diminishes Systemic Inflammatory Reactions. Journal of Immunotherapy. 30(7). 694–704. 6 indexed citations
19.
Tomihara, Kei, Kazunori Kato, Yukari Masuta, et al.. (2007). Gene transfer of the CD40‐ligand to human dendritic cells induces NK‐mediated antitumor effects against human carcinoma cells. International Journal of Cancer. 120(7). 1491–1498. 13 indexed citations
20.
Nakamori, Kenji, Akihiro Miyazaki, Hironari Dehari, et al.. (2006). STUDIES ON NECK DISSECTION IN PATIENTS WITH CARCINOMA OF THE TONGUE. Toukeibu Gan. 32(4). 429–433. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026